This multi-receptor action sets retatrutide apart from existing GLP-1 receptor agonists like semaglutide (Ozempic or Wegovy) and dual agonists like tirzepatide (Mounjaro or Zepbound)
A State-by-State Guide Reviewed by AAOPM Clinical Faculty | Updated February 2026 | 12-Minute Read Does Medicaid Cover Weight Loss Shots and Medications
Once a semaglutide pen has been used for the first time, storage requirements change based on the specific product
Asmar A, Simonsen L, Asmar M, Madsbad S, Holst JJ, Frandsen E, Moro C, Sorensen CM, Jonassen T, Bulow J
The tirzepatide in Zepbound has been shown to help people lose an average of 21% of body weight over about 72 weeks